Chief Commercial Officer · SOLENO THERAPEUTICS INC (SLNO)

Meredith Manning

FY2024 is the first fiscal year CompBrief holds for Meredith Manning as a named executive officer of SOLENO THERAPEUTICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$7,783,050

Compensation figures as of the proxy filed April 22, 2025 (DEF 14A).

Meredith Manning compensation by year

SOLENO THERAPEUTICS Summary Compensation Table · the one fiscal year held
In US dollars, as SOLENO THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$415,179
Bonus$0
Stock awards$1,947,200
Option awards$5,234,010
Non-equity incentive$173,661
Pension and deferred compensation$0
All other$13,000
Total$7,783,050

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: SOLENO THERAPEUTICS INC DEF 14A filed April 22, 2025, accession 0001193125-25-089274, and prior-year filings. Open the filing on EDGAR.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU40,000$1,798,000—
Option128,000—$46.31

Per the Outstanding Equity Awards at Fiscal Year-End table in SOLENO THERAPEUTICS INC's FY2024 proxy; value at the fiscal year-end close, as the company printed it.

SOLENO THERAPEUTICS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Anish BhatnagarCEO and Chairman of the Board$51,160,430
James MackanessChief Financial Officer$8,774,955
Meredith Manning · this pageChief Commercial Officer$7,783,050
Patricia HiranoSenior Vice President, Regulatory Affairs$6,051,410

The full SOLENO THERAPEUTICS compensation record

free company brief

This page is one person within SOLENO THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order SOLENO THERAPEUTICS's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are SOLENO THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy